Drawing for PEOPLES GENETICS

USPTO serial 76194435

PEOPLES GENETICS

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
CHICOSKI, JENNIFER D
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PEOPLES GENETICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Beth M. Kotran

BETH M KOTRAN GOODWIN, PROCTER & HOAR LLPSEVEN BECKER FARM RDROSELAND, NJ 07068UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Diagnostic reagents for scientific or research use; diagnostic test kits for scientific useACTIVE—
005Pharmaceutical diagnostic reagents for medical or clinical use, namely DNA sequences for use in genotyping, biopolymer profiling, detecting diseases, determining the progression of diseases and determining drug responsesACTIVE—
009DNA testing apparatus for carrying DNA samples, namely microtiter plates, tubes or treated capillaries for use in detecting, screening and sequencing such samples for medical, diagnostic or pharmacogenomic purposes; laboratory apparatus, scientific apparatus and instruments, namely silicon chips or beads used in the separation of nucleic acids and proteinsACTIVE—
042Research and development services for others in the pharmaceutical, medical, genetic and pharmacogenomic fields; gene sequencing services; genetic screening services for others in the areas of identification of casual mutations in genes, disease causing mutations, effect of mutations on the efficacy, safety and responsiveness of drugs and effect of mutations on disease susceptibilityACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (ABN6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Aug 27, 2003ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 5, 2003EX1GSOU EXTENSION 1 GRANTED—
Jan 17, 2003EXT1SOU EXTENSION 1 FILED—
Jan 17, 2003MAILPAPER RECEIVED—
Jul 30, 2002NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 7, 2002PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 17, 2002NPUBNOTICE OF PUBLICATION—
Oct 29, 2001CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 31, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 7, 2001CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 1, 2001DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance